ANAT2341 Course Timetable 2017: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
| Line 28: | Line 28: | ||
| 3 | | 3 | ||
| Week 1/2 development | | Week 1/2 development | ||
| width=40px|1 | | width=40px|[[ANAT2341_Lab_1|1]] | ||
| [[ANAT2341_Lab_1|Steven Fleming]] (Director of Embryology, ORIGIO) - fertility and IVF | | [[ANAT2341_Lab_1|Steven Fleming]] (Director of Embryology, ORIGIO) - fertility and IVF | ||
|-bgcolor="FAF5FF" | |-bgcolor="FAF5FF" | ||
| Line 37: | Line 37: | ||
| 5 | | 5 | ||
| ectoderm development | | ectoderm development | ||
| 2 | | [[ANAT2341_Lab_2|2]] | ||
| [[ANAT2341_Lab_2|Fabien deleRue]] (UNSW) - GM manipulation of mouse embryos | | [[ANAT2341_Lab_2|Fabien deleRue]] (UNSW) - GM manipulation of mouse embryos | ||
|- | |- | ||
| Line 46: | Line 46: | ||
| 7 | | 7 | ||
| mesoderm development | | mesoderm development | ||
| 3 | | [[ANAT2341_Lab_3|3]] | ||
| [[ANAT2341_Lab_3|Preimplantation and early implantation lab]] | | [[ANAT2341_Lab_3|Preimplantation and early implantation lab]] | ||
|-bgcolor="FAF5FF" | |-bgcolor="FAF5FF" | ||
| Line 55: | Line 55: | ||
| 9 | | 9 | ||
| respiratory development (Mark?) | | respiratory development (Mark?) | ||
| 4 | | [[ANAT2341_Lab_4|4]] | ||
| [[ANAT2341_Lab_4|Robert Gilchrest]] (UNSW) - The Reproductive Technology Revolution | | [[ANAT2341_Lab_4|Robert Gilchrest]] (UNSW) - The Reproductive Technology Revolution | ||
|- | |- | ||
| Line 64: | Line 64: | ||
| 11 | | 11 | ||
| early vascular development | | early vascular development | ||
| 5 | | [[ANAT2341_Lab_5|5]] | ||
| [[ANAT2341_Lab_5|Vashe]] (UNSW) - cardiac and vascular development | | [[ANAT2341_Lab_5|Vashe]] (UNSW) - cardiac and vascular development | ||
|-bgcolor="FAF5FF" | |-bgcolor="FAF5FF" | ||
| Line 73: | Line 73: | ||
| 13 | | 13 | ||
| head development | | head development | ||
| 6 | | [[ANAT2341_Lab_6|6]] | ||
| [[ANAT2341_Lab_6|Tennille Luker]] - craniofacial development | | [[ANAT2341_Lab_6|Tennille Luker]] - craniofacial development | ||
|- | |- | ||
| Line 82: | Line 82: | ||
| 15 | | 15 | ||
| limb development | | limb development | ||
| 7 | | [[ANAT2341_Lab_7|7]] | ||
| [[ANAT2341_Lab_7|Hongjun Shi]] (VCCRI) – somitogenesis and skeletal development | | [[ANAT2341_Lab_7|Hongjun Shi]] (VCCRI) – somitogenesis and skeletal development | ||
|-bgcolor="FAF5FF" | |-bgcolor="FAF5FF" | ||
| Line 91: | Line 91: | ||
| 17 | | 17 | ||
| genital development | | genital development | ||
| 8 | | [[ANAT2341_Lab_8|8]] | ||
| [[ANAT2341_Lab_8|Organogenesis Lab]] - with mouse and chicken embryos, work sheets, etc | | [[ANAT2341_Lab_8|Organogenesis Lab]] - with mouse and chicken embryos, work sheets, etc | ||
|- | |- | ||
| Line 102: | Line 102: | ||
| 19 | | 19 | ||
| sensory (Mark) | | sensory (Mark) | ||
| 9 | | [[ANAT2341_Lab_9|9]] | ||
| [[ANAT2341_Lab_9|Stephen Palmer]] (Novogen) - drug development in regenerative disease | | [[ANAT2341_Lab_9|Stephen Palmer]] (Novogen) - drug development in regenerative disease | ||
|-bgcolor="FAF5FF" | |-bgcolor="FAF5FF" | ||
| Line 111: | Line 111: | ||
| 21 | | 21 | ||
| integumentary development | | integumentary development | ||
| 10 | | [[ANAT2341_Lab_10|10]] | ||
| [[ANAT2341_Lab_10|Kim Beaumont]] - melanocyte development, differentiation and melanoma | | [[ANAT2341_Lab_10|Kim Beaumont]] - melanocyte development, differentiation and melanoma | ||
|- | |- | ||
| Line 120: | Line 120: | ||
| 23 | | 23 | ||
| stem cells | | stem cells | ||
| 11 | | [[ANAT2341_Lab_11|11]] | ||
| [[ANAT2341_Lab_11|Stem cell lab]] | | [[ANAT2341_Lab_11|Stem cell lab]] | ||
|-bgcolor="FAF5FF" | |-bgcolor="FAF5FF" | ||
Revision as of 10:17, 18 July 2017
| Week | Date | Lecture 1 | Lecture 2 | Lab | ||||
|---|---|---|---|---|---|---|---|---|
| Online - Mark | Face to Face - Annemiek and others (WW LG02) | (WW G08) | ||||||
| 1 | 27-Jul | 1 | Embryology introduction (Mark and Annemiek) | |||||
| 2 | 3-Aug | 2 | Fertilization | 3 | Week 1/2 development | 1 | Steven Fleming (Director of Embryology, ORIGIO) - fertility and IVF | |
| 3 | 10-Aug | 4 | Week 3 development | 5 | ectoderm development | 2 | Fabien deleRue (UNSW) - GM manipulation of mouse embryos | |
| 4 | 17-Aug | 6 | placental development | 7 | mesoderm development | 3 | Preimplantation and early implantation lab | |
| 5 | 24-Aug | 8 | endoderm development | 9 | respiratory development (Mark?) | 4 | Robert Gilchrest (UNSW) - The Reproductive Technology Revolution | |
| 6 | 31-Aug | 10 | neural development | 11 | early vascular development | 5 | Vashe (UNSW) - cardiac and vascular development | |
| 7 | 7-Sep | 12 | neural crest development | 13 | head development | 6 | Tennille Luker - craniofacial development | |
| 8 | 14-Sep | 14 | musculoskeletal development | 15 | limb development | 7 | Hongjun Shi (VCCRI) – somitogenesis and skeletal development | |
| 9 | 21-Sep | 16 | renal development | 17 | genital development | 8 | Organogenesis Lab - with mouse and chicken embryos, work sheets, etc | |
| Mid-semester break | ||||||||
| 10 | 5-Oct | 18 | endocrine development | 19 | sensory (Mark) | 9 | Stephen Palmer (Novogen) - drug development in regenerative disease | |
| 11 | 12-Oct | 20 | fetal | 21 | integumentary development | 10 | Kim Beaumont - melanocyte development, differentiation and melanoma | |
| 12 | 19-Oct | 22 | birth and revision | 23 | stem cells | 11 | Stem cell lab | |
| 13 | 26-Oct | 12 | Group Projects | |||||
